Alpha Tau Medical Ltd.
DRTS
$0.02
Change (1 day)
$3.40
Year High
$1.75
Year Low
Categories
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Alpha Tau Medical Ltd. (DRTS) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | -2,533,000 | 22.91 M | 107.39 M | 85.76 M | |
| 2022 | -643,000 | 14.49 M | 120.15 M | 106.48 M | |
| 2021 | 30.73 M | 76.99 M | 42.22 M | 32.64 M | |
| 2020 | 38.37 M | 61.42 M | 52.99 M | 47.46 M | |
| 2019 | 564 K | -1,831,000 | 31.75 M | 31.56 M | 29.83 M |